(NASDAQ: VANI) Vivani Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.88%.
Vivani Medical's earnings in 2026 is -$26,026,000.On average, 4 Wall Street analysts forecast VANI's earnings for 2026 to be -$26,043,948, with the lowest VANI earnings forecast at -$25,022,617, and the highest VANI earnings forecast at -$26,809,946.
In 2027, VANI is forecast to generate -$35,717,414 in earnings, with the lowest earnings forecast at -$34,316,731 and the highest earnings forecast at -$36,767,926.